Ewa LLC Raises Stock Position in Intuitive Surgical, Inc. $ISRG

Ewa LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 667 shares of the medical equipment provider’s stock after purchasing an additional 49 shares during the period. Ewa LLC’s holdings in Intuitive Surgical were worth $362,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chilton Capital Management LLC increased its stake in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the transaction, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a research note on Tuesday, August 19th. The Goldman Sachs Group dropped their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Finally, UBS Group lifted their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $438.04 on Thursday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a 50 day moving average price of $465.33 and a 200 day moving average price of $500.54. The firm has a market capitalization of $157.03 billion, a price-to-earnings ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business earned $1.78 earnings per share. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.